SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,631. The last known price of Bitcoin is 68,229.80907922 USD and is down -4.02 over the last 24 hours. It is currently trading on 12780 active market(s) with $42,739,134,877.94 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and pressure on key support levels dominate the discussion, with traders divided between expecting further downside and viewing the drop as an oversold buying opportunity. Traders cite macroeconomic headwinds, ETF outflows and leveraged liquidations, while some speculate that investors are shifting capital toward an anticipated AI-company IPO.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.0099454 USD and is down -2.36 over the last 24 hours. It is currently trading on 1896 active market(s) with $2,532,309,467.05 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is under pressure amid a broader crypto selloff, with traders citing hot inflation data, shifting Fed-rate expectations and leveraged long liquidations as possible headwinds while the token tests the psychologically important $1 level. The discussion is split between bearish calls for further declines and holders treating the drop as a buying opportunity.

Midnight (NIGHT) is a cryptocurrency launched in 2025and operates on the BNB Smart Chain (BEP20) platform. Midnight has a current supply of 24,000,000,000 with 16,607,399,401 in circulation. The last known price of Midnight is 0.0466466 USD and is up 2.42 over the last 24 hours. It is currently trading on 208 active market(s) with $45,021,965.41 traded over the last 24 hours. More information can be found at https://midnight.network/.

Midnight

NIGHT is drawing attention for a high-volume rebound and attempts to break resistance, with traders debating whether the move can continue amid ongoing token selling. Bullish discussion points to Midnights live network and a reported Monument Bank tokenization plan, while skeptics cite limited adoption and concerns about centralization and airdrop supply.

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,738,272,860.16806072. The last known price of Dogecoin is 0.06457313 USD and is down -2.71 over the last 24 hours. It is currently trading on 1545 active market(s) with $672,498,596.98 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoin is being discussed amid a broad crypto-market selloff and sustained losses, with many traders worried the decline will continue and questioning the coins value or relevance. Others view the weakness as a buying opportunity and point to possible technical signs of a rebound, leaving sentiment sharply divided.

Litecoin (LTC) is a cryptocurrency . Users are able to generate LTC through the process of mining. Litecoin has a current supply of 84,000,000 with 77,827,248.80032983 in circulation. The last known price of Litecoin is 49.45346856 USD and is down -1.54 over the last 24 hours. It is currently trading on 1567 active market(s) with $228,945,256.48 traded over the last 24 hours. More information can be found at https://litecoin.org/.

Litecoin

Litecoins decline below a key trading range and into the $40s is driving discussion, with traders flagging bearish momentum and possible further support breaks. Others view the pullback as an accumulation opportunity, creating a clear divide between concern over persistent underperformance and dip-buying optimism.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,964,197.93006099. The last known price of Zcash is 932.62986485 USD and is down -2.50 over the last 24 hours. It is currently trading on 670 active market(s) with $1,142,095,783.67 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcash is drawing attention amid a sharp, volatile pullback after a strong rally, with traders debating whether the decline is a capitulation and buying opportunity or whether further losses lie ahead. Some attribute the weakness to broader crypto-market selling and liquidations, while others point to Zcashs recent network upgrade and privacy-focused appeal as reasons for optimism.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit is drawing attention ahead of the FDAs decision on ivonescimab for EGFR-mutated lung cancer, with traders treating the outcome as a high-stakes binary catalyst. The debate centers on strong progression-free-survival results and favorable updated survival trends versus the FDAs stated need for statistically significant overall-survival evidence, fueling uncertainty and volatile positioning.

XMAX, Inc. engages in design, marketing, and manufacture of modern home furniture. The firm offers living room, urban dining, bedroom, and nova qwik products. Its brands include Nova LifeStyle, Diamond Sofa, and Nova Living. The company was founded by Ya Ming Wong and Yuen Ching Ho in 1992 and is headquartered in Commerce, CA.

XMax Inc.

XMaxs AI pivot is driving attention, particularly its five-year Korean AI infrastructure agreement for dedicated NVIDIA GPU capacity, alongside a share-repurchase authorization and preliminary quarterly results. Bulls view the infrastructure plans and AI services as concrete progress, while skeptics point to the declining legacy furniture business and say commercial execution remains unproven.

Freeport-McMoRan, Inc. engages in the mining of copper, gold, and molybdenum. It operates through the following segments: U.S. Copper Mines, South America Operations, Indonesia Operations, Molybdenum Mines, U.S. Rod and Refining, Atlantic Copper, and Corporate and Other. The U.S. Copper Mines segment operates open-pit copper mines in Morenci, Bagdad, Safford, Sierrita, Miami in Arizona and Chino, and Tyrone in New Mexico. The South America Operations segment includes Cerro Verde in Peru and El Abra in Chile. The Indonesia Operations segment handles the operations of the Grasberg minerals district that produce copper concentrate containing significant quantities of gold and silver. The Molybdenum Mines segment includes the Henderson underground mine and Climax open pit mine, both in Colorado. The U.S. Rod and Refining segment consists of copper conversion facilities located in North America and includes refinery and rod mills. The Atlantic Copper segment smelts and refines copper concentrate and markets refined copper and precious metals in slimes. The Corporate and Other segment offers other mining and eliminations, oil and gas operations, and other corporate and elimination items. The company was founded by James R. Moffett on November 10, 1987, and is headquartered in Phoenix, AZ.

Freeport-McMoRan Inc

FCX is under pressure amid a pullback in copper and worries about near-term demand, with traders also pointing to delayed Grasberg ramp-up and reduced sales guidance as company-specific headwinds. The debate pits those near-term risks against the long-term copper-demand and supply-tightness thesis, prompting some traders to buy dips while others expect further weakness.

Aero (AERO) is a cryptocurrency launched in 2023and operates on the Base platform. Aero has a current supply of 2,140,889,212.87723348 with 1,064,756,795.37035192 in circulation. The last known price of Aero is 0.47070254 USD and is down -9.41 over the last 24 hours. It is currently trading on 522 active market(s) with $66,608,274.32 traded over the last 24 hours. More information can be found at https://aero.xyz.

Aerodrome Finance

Aerodromes Predictive Allocation upgrade, protocol buybacks, and anticipated multi-chain/Ethereum mainnet expansion are driving discussion, with traders viewing them as potential growth catalysts. Optimism about the recent run and tokenized-asset opportunity is tempered by concerns about pullbacks, resistance, and whether the launch-related excitement will hold.

statis crypto Watchlist

Ethereum

Solana

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$MANE mark my words... in a matter of months, maybe one year.... $ABSI will SURPASS $MANE and LEAD the hair loss revolution

StockTwits Web

Veradermics Inc

Absci Corp

 mark my words... in a matter of months, maybe one year.... 

Justin F

@jfat2hee2 $MANE VDPHL01 is an extended-release minoxidil pill for hair loss. In Phase 3, 68.7% of men on the twice-daily dose rated their hair coverage improved or much improved, against 15% on placebo. The bigger test comes in the first half of 2027: the results in 556 women.

 VDPHL01 is an extended-release minoxidil pill for hair loss. In Phase 3, 68.7% of men on the twice-daily dose rated their hair coverage improved or much improved, against 15% on placebo. The bigger test comes in the first half of 2027: the results in 556 women.